Tag Archives: BLUE

Friday’s Highlights at Noon: Organovo Holdings (ONVO), Novavax (NVAX), TG Therapeutics (TGTX), Whiting Petroleum Corporation (WLL), Bluebird Bio (BLUE)

So far Friday, September 4, NASDAQ is down -11.74% and the S&P is down -6.24%. Here are this morning’s most active stocks: Organovo Holdings (ONVO – Research Report), Novavax (NVAX – Research Report), TG Therapeutics (TGTX – Research Report), Whiting

Oppenheimer Gives a Buy Rating to Bluebird Bio (BLUE)

In a report released today, Mark Breidenbach from Oppenheimer assigned a Buy rating to Bluebird Bio (BLUE – Research Report), with a price target of $111.00. The company’s shares closed last Friday at $56.75. According to TipRanks.com, Breidenbach is a

William Blair Sticks to Their Hold Rating for Bluebird Bio (BLUE)

William Blair analyst Raju Prasad maintained a Hold rating on Bluebird Bio (BLUE – Research Report) today. The company’s shares closed last Friday at $56.75. According to TipRanks.com, Prasad is a 5-star analyst with an average return of 15.6% and

Analysts Offer Insights on Healthcare Companies: Bluebird Bio (NASDAQ: BLUE) and Nurix Therapeutics (NASDAQ: NRIX)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Bluebird Bio (BLUE – Research Report) and Nurix Therapeutics (NRIX – Research Report) with bullish sentiments. Bluebird Bio (BLUE) In a report

Tuesday’s Midday Stock Update: Inovio Pharmaceuticals (INO), TG Therapeutics (TGTX), Bluebird Bio (BLUE), Cytokinetics (CYTK), Novagold Resources New (NG)

So far Tuesday, July 7, NASDAQ is up 2.11% and the S&P is up 0.93%. Here are this morning’s most active stocks: Inovio Pharmaceuticals (INO – Research Report), TG Therapeutics (TGTX – Research Report), Bluebird Bio (BLUE – Research Report),

Analysts Offer Insights on Healthcare Companies: Bluebird Bio (NASDAQ: BLUE), Centene (NYSE: CNC) and Vertex Pharmaceuticals (NASDAQ: VRTX)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Bluebird Bio (BLUE – Research Report), Centene (CNC – Research Report) and Vertex Pharmaceuticals (VRTX – Research Report) with bullish sentiments. Bluebird